Descripción del proyecto
Un sistema de cirugía robótica con retroalimentación háptica
Muchas técnicas quirúrgicas intravasculares, como la operación quirúrgica vascular periférica y las intervenciones coronarias, requieren el empleo de robots, lo que protege al personal médico de la exposición a rayos X perjudiciales. En el proyecto HAPGuide, financiado con fondos europeos, se ha desarrollado un sistema robótico novedoso que permite la retroalimentación háptica y el control tradicional de los instrumentos intravasculares. Gracias a este sistema, los cirujanos mantienen su nivel de percepción, visualización y acción, sin necesidad de instrumentos especializados o catéteres costosos. El objetivo principal de HAPGuide es llevar esta tecnología innovadora a la práctica clínica para que las intervenciones quirúrgicas intravasculares sean más seguras, rápidas y eficaces en todo el mundo, lo que beneficiará a pacientes, médicos y hospitales.
Objetivo
"UAB ""Inovatyvi medicina"" has developed an innovative design of endovascular robotic system HAPGuide. This SMART and SENSING technology allows to perform endovascular procedures without medical personnel being exposed to harmful X-rays. HAPGuide solves the main issues of existing robotic systems and opens up possibilities for safer, faster and more effective endovascular interventions in EU and Worldwide. In comparison to existing systems (with only visual feedback and videogame like control) the main HAPGuide advantage is the haptic feedback and traditional control of endovascular instruments using fine-tuned surgeons’ perception-action-visualization abilities. Future developments involve HAPGuide use in telemedicine and partially automated functions via machine learning. Our system is designed to use all standard endovascular instruments and avoids the need of expensive catheters dedicated for the system. The primary target market of HAPGuide is cath labs performing percutaneous coronary interventions and peripheral vascular procedures in EU and US (more than 5.6 mln. procedures annually). The estimated market potential of HAPGuide robotic system in primary worldwide market exceeds €4 billion. The secondary target market would involve neurointerventional procedures while in the long-run expansion to telerobotics will create new market opportunities. Our revenue model involves four main components: 1) durable robotic HAPGuide system; 2) single use cassette; 3) annual service of the system; 4) HAPLearn training software. A multidisciplinary team with vast experience in medical sciences, medical device development, robotics, mechanical and electronic engineering, product design, commercialisation and business development has joined forces for the implementation of HAPGuide project aiming to bring the technology to clinical practice for benefit of patients, physicians and hospitals and exploit this €4 billion niche market commercial opportunity."
Ámbito científico
- medical and health sciencesclinical medicinecardiologycardiovascular diseases
- medical and health sciencesbasic medicineneurologystroke
- engineering and technologyelectrical engineering, electronic engineering, information engineeringelectronic engineeringrobotics
- natural sciencescomputer and information sciencesartificial intelligencemachine learning
- natural sciencescomputer and information sciencessoftwaresoftware applicationsvideo games
Programa(s)
Convocatoria de propuestas
Consulte otros proyectos de esta convocatoriaConvocatoria de subcontratación
H2020-SMEInst-2018-2020-1
Régimen de financiación
SME-1 - SME instrument phase 1Coordinador
44353 KAUNAS
Lituania
Organización definida por ella misma como pequeña y mediana empresa (pyme) en el momento de la firma del acuerdo de subvención.